• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细胞的放射免疫测定法,用于定量针对细胞内抗原的三硝基甲苯单克隆抗体的免疫反应性。

Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigens.

作者信息

Gaffar S A, Chen F M, Liu C, Epstein A L

机构信息

University of Southern California-School of Medicine, Department of Pathology, Los Angeles 90033.

出版信息

J Immunoassay. 1991;12(1):1-14. doi: 10.1080/01971529108055053.

DOI:10.1080/01971529108055053
PMID:2040706
Abstract

Direct and indirect radioimmunoassay (RIA) procedures to determine the amount of binding of a mouse monoclonal antibody (MoAb) reactive with an intracellular antigen present in human cells are described. In these RIAs, mouse IgG2a MoAb, designated as Tumor Necrosis Treatment (TNT-1) antibody, paraformaldehyde/acetone fixed cells, and Sephadex beads were used to standardize the assay conditions. In the direct RIA, 83% of the 125I-labeled TNT-1 MoAb was bound to the target cells within 30 min after the addition of reagents. The amount of binding of the MoAb was directly proportional to the amount of antigen present in the assay. When the direct RIA was carried out using different types of target cells, 125I-labeled TNT-1 MoAb showed greater than 70% binding. In the indirect RIA, the amount of binding of secondary 125I-labeled goat anti-mouse IgG antibody to the target cells was linear. These results suggest that the indirect RIA can be used to estimate the immunoreactivity of the unlabeled TNT-1 MoAb present in crude protein preparations. Based on the results of RIAs the following two conclusions are drawn: 1) the direct RIA can be used to estimate rapidly the amount of immunoreactive TNT-1 MoAb present in 125I-labeled antibody preparations and 2) the indirect RIA which estimates the amount of immunoreactivity of unlabeled TNT-1 MoAb can be used to monitor the purification and study the characteristics of the MoAb present in crude protein preparations. These methods enable the quantitative measurement of MoAbs reactive against intracellular antigens using standard RIA procedures.

摘要

本文描述了直接和间接放射免疫测定(RIA)程序,用于测定与人类细胞中存在的细胞内抗原发生反应的小鼠单克隆抗体(MoAb)的结合量。在这些RIA中,使用了指定为肿瘤坏死治疗(TNT-1)抗体的小鼠IgG2a MoAb、多聚甲醛/丙酮固定细胞和葡聚糖凝胶珠来标准化测定条件。在直接RIA中,添加试剂后30分钟内,125I标记的TNT-1 MoAb中有83%与靶细胞结合。MoAb的结合量与测定中存在的抗原量成正比。当使用不同类型的靶细胞进行直接RIA时,125I标记的TNT-1 MoAb显示出大于70%的结合率。在间接RIA中,二级125I标记的山羊抗小鼠IgG抗体与靶细胞的结合量呈线性关系。这些结果表明,间接RIA可用于估计粗蛋白制剂中存在的未标记TNT-1 MoAb的免疫反应性。基于RIA的结果得出以下两个结论:1)直接RIA可用于快速估计125I标记抗体制剂中存在的免疫反应性TNT-1 MoAb的量;2)估计未标记TNT-1 MoAb免疫反应性的间接RIA可用于监测粗蛋白制剂中MoAb的纯化并研究其特性。这些方法能够使用标准RIA程序对针对细胞内抗原的MoAb进行定量测量。

相似文献

1
Cell based radioimmunoassays to quantitate the immunoreactivity of TNT monoclonal antibodies directed against intracellular antigens.基于细胞的放射免疫测定法,用于定量针对细胞内抗原的三硝基甲苯单克隆抗体的免疫反应性。
J Immunoassay. 1991;12(1):1-14. doi: 10.1080/01971529108055053.
2
Detection of malignant melanoma with monoclonal antibodies.用单克隆抗体检测恶性黑色素瘤
Dis Markers. 1988 Jun;6(2):97-108.
3
Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.抗胚胎抗原的小鼠单克隆抗体:制备、与啮齿动物及人类肿瘤的交叉反应性及初步的多肽特性分析
J Natl Cancer Inst. 1985 Sep;75(3):527-44.
4
Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography.利用体外定量放射自显影法测量人黑色素瘤肿瘤切片中局部分子量为97,000和250,000的蛋白质抗原浓度。
Cancer Res. 1988 Oct 1;48(19):5475-81.
5
Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.针对小鼠组织和人肿瘤异种移植瘤的特异性大鼠单克隆抗体的微分布
Cancer Res. 1991 Mar 1;51(5):1529-36.
6
Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.小鼠抗人高分子量黑色素瘤相关抗原单克隆抗体与豚鼠黑色素瘤细胞的交叉反应性。
Cancer Res. 1987 Sep 15;47(18):4835-41.
7
Effects of target antigen competition on distribution of monoclonal antibody to solid tumors.靶抗原竞争对单克隆抗体在实体瘤中分布的影响。
Cancer Res. 1992 Mar 1;52(5):1284-90.
8
Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.在携带Raji伯基特淋巴瘤异种移植瘤的裸鼠中使用未标记和131I标记的全B细胞单克隆抗体进行治疗。
Cancer Res. 1992 Dec 1;52(23):6476-81.
9
A comparative autoradiographic study demonstrating differential intratumor localization of monoclonal antibodies to cell surface (Lym-1) and intracellular (TNT-1) antigens.一项比较放射自显影研究,展示了针对细胞表面(Lym-1)和细胞内(TNT-1)抗原的单克隆抗体在肿瘤内的不同定位。
J Nucl Med. 1990 Jun;31(6):1059-66.
10
Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.使用偶联和非偶联单克隆抗体进行人类癌症检测与免疫治疗。
Anticancer Res. 1996 Mar-Apr;16(2):661-74.

引用本文的文献

1
Effects of 131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids.131I标记的TNT-1放射免疫疗法对HT-29人结肠腺癌球体的影响。
Cancer Immunol Immunother. 1991;33(3):158-64. doi: 10.1007/BF01756136.